Literature DB >> 3948196

Phase II clinical trial of diaziquone in the treatment of patients with epithelial ovarian cancer: a Gynecologic Oncology Group Study.

R E Slayton, J A Blessing, G P Sutton, H D Homesley, R Park.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3948196

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.

Authors:  R E Slayton; J A Blessing; M Rettenmaier; H Ball
Journal:  Invest New Drugs       Date:  1989-11       Impact factor: 3.850
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.